148 related articles for article (PubMed ID: 19342969)
1. Conditioning vaccination site with irradiated MIP-3alpha-transfected tumor cells enhances efficacy of dendritic cell-based cancer vaccine.
Shih NY; Yang HY; Cheng HT; Hung YM; Yao YC; Zhu YH; Wu YC; Liu KJ
J Immunother; 2009 May; 32(4):363-9. PubMed ID: 19342969
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of MIP-1alpha-recruited dendritic cells on preestablished solid and metastatic tumors.
Cao Q; Jin Y; Jin M; He S; Gu Q; He S; Qiu Y; Ge H; Yoneyama H; Zhang Y
Cancer Lett; 2010 Sep; 295(1):17-26. PubMed ID: 20202744
[TBL] [Abstract][Full Text] [Related]
3. Novel membrane-bound GM-CSF vaccines for the treatment of cancer: generation and evaluation of mbGM-CSF mouse B16F10 melanoma cell vaccine.
Yei S; Bartholomew RM; Pezzoli P; Gutierrez A; Gouveia E; Bassett D; Soo Hoo W; Carlo DJ
Gene Ther; 2002 Oct; 9(19):1302-11. PubMed ID: 12224013
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses.
Weigel BJ; Panoskaltsis-Mortari A; Diers M; Garcia M; Lees C; Krieg AM; Chen W; Blazar BR
Exp Hematol; 2006 Oct; 34(10):1403-12. PubMed ID: 16982333
[TBL] [Abstract][Full Text] [Related]
5. Administration of MIP-3alpha gene to the tumor following radiation therapy boosts anti-tumor immunity in a murine model of lung carcinoma.
Zhu B; Zou L; Cheng X; Lin Z; Duan Y; Wu Y; Zhou F; Chen Z
Immunol Lett; 2006 Mar; 103(2):101-7. PubMed ID: 16257060
[TBL] [Abstract][Full Text] [Related]
6. [Enhanced translational efficacy of internal ribosomal entry site-mediated mRNA in dendritic cells contributes to efficient induction of antitumor immunity].
Tan XH; Wan YH
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):399-403. PubMed ID: 17456382
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic dendritic cell vaccination with Ag coupled to cholera toxin in combination with intratumoural CpG injection leads to complete tumour eradication in mice bearing HPV 16 expressing tumours.
Chandy AG; Nurkkala M; Josefsson A; Eriksson K
Vaccine; 2007 Aug; 25(32):6037-46. PubMed ID: 17629599
[TBL] [Abstract][Full Text] [Related]
8. Correlation of dendritic cell infiltration with active crypt inflammation in ulcerative colitis.
Watanabe S; Yamakawa M; Hiroaki T; Kawata S; Kimura O
Clin Immunol; 2007 Mar; 122(3):288-97. PubMed ID: 17178254
[TBL] [Abstract][Full Text] [Related]
9. Intravenous administration of MIP-1alpha with intra-tumor injection of P. acnes shows potent anti-tumor effect.
Nakano A; Yoneyama H; Ueha S; Kitabatake M; Ishikawa S; Kawase I; Sugiyama H; Matsushima K
Int Immunopharmacol; 2007 Jun; 7(6):845-57. PubMed ID: 17466918
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
Kim S; Lee JB; Lee GK; Chang J
Prostate; 2009 Jun; 69(9):938-48. PubMed ID: 19267351
[TBL] [Abstract][Full Text] [Related]
11. Microencapsulation of tumor lysates and live cell engineering with MIP-3α as an effective vaccine.
Huang FY; Huang FR; Chen B; Liu Q; Wang H; Zhou SL; Zhao HG; Huang YH; Lin YY; Tan GH
Biomaterials; 2015; 53():554-65. PubMed ID: 25890751
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
13. Sustained cytokine delivery for anticancer vaccination: liposomes as alternative for gene-transfected tumor cells.
Koppenhagen FJ; Küpcü Z; Wallner G; Crommelin DJ; Wagner E; Storm G; Kircheis R
Clin Cancer Res; 1998 Aug; 4(8):1881-6. PubMed ID: 9717815
[TBL] [Abstract][Full Text] [Related]
14. Vaccinations with dendritic cells primed with apoptotic tumor cells can elicit preventive antitumor immunity in a poorly immunogenic animal model of squamous cell carcinoma.
Jeong HS; Lee H; Ko Y; Son YI
Laryngoscope; 2007 Sep; 117(9):1588-93. PubMed ID: 17597627
[TBL] [Abstract][Full Text] [Related]
15. MIP-3alpha transfection into a rodent tumor cell line increases intratumoral dendritic cell infiltration but enhances (facilitates) tumor growth and decreases immunogenicity.
Bonnotte B; Crittenden M; Larmonier N; Gough M; Vile RG
J Immunol; 2004 Oct; 173(8):4929-35. PubMed ID: 15470034
[TBL] [Abstract][Full Text] [Related]
16. Modification of dendritic cells with interferon-gamma-inducible protein-10 gene to enhance vaccine potency.
Kang TH; Bae HC; Kim SH; Seo SH; Son SW; Choi EY; Seong SY; Kim TW
J Gene Med; 2009 Oct; 11(10):889-98. PubMed ID: 19618483
[TBL] [Abstract][Full Text] [Related]
17. MIP-3alpha and MIP-1alpha rapidly mobilize dendritic cell precursors into the peripheral blood.
He S; Cao Q; Yoneyama H; Ge H; Zhang Y; Zhang Y
J Leukoc Biol; 2008 Dec; 84(6):1549-56. PubMed ID: 18791167
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with dendritic cells charged with apoptotic/necrotic B16 melanoma induces the formation of subcutaneous lymphoid tissue.
Mac Keon S; Gazzaniga S; Mallerman J; Bravo AI; Mordoh J; Wainstok R
Vaccine; 2010 Nov; 28(51):8162-8. PubMed ID: 20937314
[TBL] [Abstract][Full Text] [Related]
19. Preventive and therapeutic antitumor effect of tumor vaccine composed of CpG ODN class C and irradiated tumor cells is triggered through the APCs and activation of CTLs.
Novaković S; Stegel V; Kopitar A; Ihan A; Novaković BJ
Vaccine; 2007 Nov; 25(49):8241-56. PubMed ID: 17980936
[TBL] [Abstract][Full Text] [Related]
20. Treatment with an immature dendritic cell-targeting vaccine supplemented with IFN-α and an inhibitor of DNA methylation markedly enhances survival in a murine melanoma model.
Gordy JT; Luo K; Kapoor A; Kim ES; Ayeh SK; Karakousis PC; Markham RB
Cancer Immunol Immunother; 2020 Apr; 69(4):569-580. PubMed ID: 31980915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
